A2GOLD COMMENCES CORE DRILLING AT EASTSIDE TARGETING RESOURCE EXPANSION
PROVIDES RC DRILLING EXPLORATION UPDATETONOPAH, Nev., April 21, 2026 /PRNewswire/ - A2Gold Corp. ("A2Gold" or the "Company") (TSXV: AUAU) (OTCQX: AUXXF)...
Read moreDetails
Press Releases – Lifestyle
Hycroft Engages Engineering Firm to Assess Underground Mining Options
Project UpdateInclusion in VanEck GDXJ ETFWINNEMUCCA, Nev., April 21, 2026 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft" or "the...
Read moreDetails
A Custom Song for Mom: PrayerSong Gives Families a Mother’s Day Gift Built from Her Story, Delivered in a Week
With faith at a 15-year high and mothers as the spiritual center of American households, PrayerSong helps families create an...
Read moreDetailsShareholders who lost money in Gemini Space Station, Inc. (NASDAQ: GEMI) Should Contact Wolf Haldenstein Immediately
Lead Plaintiff Deadline is May 18, 2026NEW YORK, April 21, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP informs...
Read moreDetailsDENARIUS METALS ANNOUNCES INCREASED PROPOSAL TO ACQUIRE EMERITA RESOURCES CORP.
Increased all‑share proposal to acquire Emerita Resources at CA$0.45 per share, implying an approximate 73% premium to Emerita's closing price...
Read moreDetailsBlue Moon Metals and Alpha Future Funds S.C.S. Announce Non-Binding Agreement to Combine Holdings in the Sulitjelma Mining District, Norway
TORONTO, April 21, 2026 /PRNewswire/ - Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV: MOON) (NASDAQ: BMM) and...
Read moreDetails
Early Immune Changes May Signal Increased Risk of Alzheimer’s and Dementia
NEW YORK, April 21, 2026 /PRNewswire/ -- Circulating white blood cells called neutrophils are some of the immune system's first...
Read moreDetails
Kairoi Residential Named to NMHC’s 2026 Top 50 Managers List
First-Time Recognition Reflects Firm's Intentional Growth and Distinctive Hospitality-Driven ApproachSAN ANTONIO, April 21, 2026 /PRNewswire/ -- Kairoi Residential, a premier,...
Read moreDetailsEfemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease
Novel bioresorbable scaffold demonstrates primary patency rate of 97% at 3 years, indicative of long-term efficacyAchieved 1% post-procedural residual stenosis...
Read moreDetailsFLANGE FACING TOOL FEATURES EASY MANUAL OPERATION
HOLLISTON, Mass., April 21, 2026 /PRNewswire/ -- Esco Tool has introduced a manually operated flange facing tool that is easy...
Read moreDetails